Inclusion complexes of bendamustine with β-CD, HP-β-CD and Epi-β-CD: in-vitro and in-vivo evaluation

References

• Zhang J, Lan CQ, Post M. Design of nanoparticles as drug carriers for cancer therapy. Cancer Genomics Proteomics 2006;3:147–58
   PubMedGoogle Scholar
• Dai W, Pollock-Dove C, Dong LC, Li S. Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation. Adv Drug Deliv Rev 2008;60:657–67
   PubMed Web of Science ®Google Scholar
• Kath R, Blumenstengel K, Fricke HJ, Hoffken K. Bendamustine mono therapy in advanced and refractory chronic lymphocytic leukemia. J Cancer Res Clin 2011;127:48–54
   Web of Science ®Google Scholar
• Bagchi, S. Bendamustine for advanced sarcoma. Lancet Oncol 2007;8:674–7
   PubMed Web of Science ®Google Scholar
• Ravikanth M, Babu PS, Rao MVB, Allamneni Y. Formulation and evaluation of stable lyophilized bendamustine hydrochloride injection. Int J Pharm Sci Rev Res 2013;23:89–93
   Google Scholar
• Pavani PB, Vasanth PM, Ramesh T, Ramesh M. A stability indicating RP-HPLC method for the determination of bendamustine hydrochloride in parenterals. Int J Bioassay 2012;2:260–4
   Google Scholar
• Prasanna S, Puranik SB. Preparation and evaluation of bendamustine hydrochloride non aqueous formulations. Int J Pharm Res Scholar 2013;2: 136–9
   Google Scholar
• Vyas A, Saraf S. Cyclodextrin based novel drug delivery systems. J Incl Phenom Macrocyclic Chem 2008;62:23–42
   Web of Science ®Google Scholar
• Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 1996;85:1017–25
   PubMed Web of Science ®Google Scholar
• Riekes MK, Tagliari MP, Granada A, et al. Enhanced solubility and dissolution rate of amiodarone by complexation with β-cyclodextrin through different methods. Mater Sci Eng C 2010;30:1008–13
   Web of Science ®Google Scholar
• Ge X, Huang G, Tian S, et al. Complexation of carbendazim with hydroxypropyl-β-cyclodextrin to improve solubility and fungicidal activity. Carbohyd Polym 2012;89:208–12
   PubMed Web of Science ®Google Scholar
• Renard E, Deratani A, Volet G, Sebille B. Preparation and characterization of water soluble high molecular weight β-cyclodextrin-epichlorohydrin polymers. Eur Polym J 1997;33:49–57
   Web of Science ®Google Scholar
• Gidwani B, Vyas A. Synthesis, characterization and application of epichlorohydrin-β-cyclodextrin polymer. Coll Surface B 2014;114:130–7
   PubMed Web of Science ®Google Scholar
• Mura P, Faucci MT, Maestrelli S, et al. Characterization of physiochemical properties of naproxen systems with amorphous β-cyclodextrin-epichlorohydrin polymers. J Pharm Biomed 2002;29:1015–24
   PubMed Web of Science ®Google Scholar
• Jug M, Maestrelli F, Bragagni M, Mura P. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery. J Pharm Biomed 2010;52:9–18
   PubMed Web of Science ®Google Scholar
• Cirri M, Bragagni M, Mennini N, Mura P. Development of a new delivery system consisting in “drug-in cyclodextrin-in nanostructured lipid carriers” for ketoprofen topical delivery. Eur J Pharm Biopharm 2012;80:46–53
   PubMed Web of Science ®Google Scholar
• Jug M, Kosalec I, Maestrelli F, Mura P. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative. J Pharm Biomed 2011;54:1030–9
   PubMed Web of Science ®Google Scholar
• Nie S, Zhang S, Pan W, Liu Y. In-vitro and in-vivo studies on the complexes of glipizide with water-soluble β-cyclodextrin–epichlorohydrin polymers. Drug Dev Ind Pharm 2011;37:606–12
   PubMed Web of Science ®Google Scholar
• Xin J, Guo Z, Chen X, et al. Study of branched cationic β-cyclodextrin polymer/indomethacin complex and its release profile from alginate hydrogel. Int J Pharm 2010;386:221–8
   PubMed Web of Science ®Google Scholar
• Ascenso A, Guedes R, Bernardino R, Marques HC. Complexation and full characterization of the tretinoin and dimethyl-βeta-cyclodextrin complex. AAPS PharmSciTech 2011;12:553–62
   PubMed Web of Science ®Google Scholar
• Loftsson T, Hreinsdottir D, Masson M. Evaluation of cyclodextrin solubilization of drugs. Int J Pharm 2005;302:18–28
   PubMed Web of Science ®Google Scholar
• Vyas A. Encapsulation of cyclodextrin complexed simvastatin in chitosan nanocarriers: a novel technique for oral delivery. J Incl Phenom Macrocyclic Chem 2010;66:251–9
   Web of Science ®Google Scholar
• Zeng J, Ren Y, Zhou C, et al. Preparation and physicochemical characteristics of the complex of edaravone with hydroxypropyl-β-cyclodextrin. Carbohyd Polym 2011;83:1101–5
   Web of Science ®Google Scholar
• Challa R, Ahuja A, Ali J, Khar R. Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech 2005;6:329–57
   PubMed Web of Science ®Google Scholar
• Higuchi T, Connors KA. Phase-solubility techniques. In: Reilly CN, ed. Advances in analytical chemistry and instrumentation. New York: Wiley; 1965:117–212
   Google Scholar
• Gidwani B, Vyas A. Formulation, characterization and evaluation of cyclodextrin-complexed bendamustine-encapsulated PLGA nanospheres for sustained delivery in cancer treatment. Pharm Dev Technol 2014. [Epub ahead of print]. doi:10.3109/10837450.2014.979945
   PubMedGoogle Scholar
• Babu RJ, Pandit JK. Enhancement of dissolution rate and hypoglycemic activity of glibenclamide with β-cyclodextrin. STP Pharma Sci 1995;5:196–201
   Google Scholar
• Veiga F, Fernandes C, Maincent P. Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary system. Drug Dev Ind Pharm 2001;27:523–32
   PubMed Web of Science ®Google Scholar
• Sinha VR, Goel HA. In-vivo bioavailability and therapeutic assessment of host–guest inclusion phenomena for the hydrophobic molecule etodolac: pharmacodynamic and pharmacokinetic evaluation. Sci Pharm 2010;78:103–15
   PubMedGoogle Scholar
• Ma Y, Zhao X, Li J, Shen Q. The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability. Int J Nanomed 2012;7:559–70
   PubMed Web of Science ®Google Scholar
• Jiang Y, Sha X, Zhang W, Fang X. Complex of 9-nitro-camptothecin in hydroxypropyl-β-cyclodextrin: in-vitro and in-vivo evaluation. Int J Pharm 2010;397:116–21
   PubMed Web of Science ®Google Scholar